Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World April 1, 2014 Emma Stoye	New Centers for Doctoral Training announced Chancellor of the Exchequer George Osborne has announced the UK will fund another 22 Centers for Doctoral Training, taking the total government investment in CDTs over 500 million pounds.
Chemistry World May 28, 2008 Mark Peplow	Cancer research gets collaborative funding boost In an effort to crack some of the biggest problems in cancer drug discovery, Cancer Research UK has launched a unique funding program that promises to help bridge the gap between fundamental research and big pharma pipelines.
Pharmaceutical Executive July 3, 2007 Sarah Houlton	Global Report: Five-Year Survivor: European Edition The UK government's attitude seems to be that oncology treatments are hugely expensive -- and that too much of the National Health Service budget is vanishing into the pockets of drug companies. Will cancer networks fill the gap?
Science News May 13, 2000	Cancer Net CancerNet is a huge compendium of information on cancer assembled by the National Cancer Institute....
Pharmaceutical Executive November 1, 2005 Sarah Houlton	Global Report: Drug Evaluation in the UK The availability of new medicines has been thrown into the limelight once more, with UK's National Institute for Health and Clinical Excellence being called upon to make dramatic improvements to the speed at which it carries out evaluations.
Chemistry World August 9, 2010 Leila Sattary	Microfinancing to solve academic poverty? With budget cuts starting to bite and a fresh wave of bad news expected in the Comprehensive Spending Review in October 2010, UK scientists are looking for new ways to finance their research.
Chemistry World September 7, 2015	Cancer Drugs Fund axes 23 treatments The Cancer Drugs Fund, which covers the cost of some cancer treatments that are not currently available on the National Health Service, has cut 23 treatments -- involving 16 drugs.
Chemistry World May 4, 2006 Katharine Sanderson	Cancer Charity Takes on Shelved Drugs Cancer Research UK, and its commercial arm, Cancer Research Technology have launched a clinical development partnership scheme to sweep up drug candidates that pharmaceuticals companies have deprioritized for not showing enough commercial promise.
Fast Company July 1, 2007	Going on the Gold Standard What it takes for your company to join the cancer fight.
Chemistry World November 25, 2013 Patrick Walter	New doctoral training centers get go ahead UK science minister David Willetts has announced 72 new centers to train more than 3500 PhD students over the next four years.
American Family Physician May 15, 2005	Early Prostate Cancer: What You Should Know A patient hand-out on the disease, who is at risk, diagnosis and treatment options.
Chemistry World June 25, 2013 Emma Stoye	NHS to offer breast cancer prevention drugs New guidelines for the UK National Health Service suggest that women at high risk of breast cancer should be offered a five-year course of tamoxifen or raloxifene to prevent the disease developing.
BusinessWeek May 23, 2005 Catherine Arnst	If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer.
Science News May 19, 2007	Science Safari: Cancer Risk -- Understanding the Puzzle This new Web site from the National Cancer Institute cuts through the hype to help you understand the plain and simple truth about cancer risk.
Chemistry World August 23, 2012 Simon Campbell	Protecting patients at all costs A new funding model is urgently required to deliver innovative medicines that meet the medical needs of the 21st century and contribute to economic growth.
Chemistry World May 24, 2011 Leila Sattary	Technology centers to learn from past mistakes The UK government has told the Technology Strategy Board it needs to learn from previous failures if it is to turn academic research into economic success as it rolls out the technology and innovation centers.
Chemistry World July 10, 2015 Angeli Mehta	Business unable to access knowledge locked up in universities A bewildering array of organizations and schemes to support collaborative research between businesses and universities in the UK is leading to frustration and confusion, and needs to be simplified.
The Motley Fool April 26, 2004 Alyce Lomax	Genentech's Lucky Day Genentech and OSI Pharmaceuticals jump in today's trading session after favorable trial results for a cancer drug.
Chemistry World January 21, 2011 Jennifer Newton	Early lung cancer diagnosis Patients with lung cancer have elevated levels of a specific protein in their blood that could be used as a biomarker for the disease, say scientists from South Korea.
Chemistry World December 5, 2008 Matt Wilkinson	250m to train new breed of UK scientists The UK's Engineering and Physical Sciences Research Council has selected 44 new centers to share a 250 million injection into postgraduate science education.
Managed Care March 2007 Martin Sipkoff	Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails.
Chemistry World October 11, 2007 Ananyo Bhattacharya	Exclusive Interview: EPSRC's New Chief Executive, David Delpy UK chemists have been too content to 'fill the gaps' instead of tackling big, exciting problems. That's the view of medical physicist David Delpy, who recently started work as the chief executive of the Engineering and Physical Sciences Research Council.
The Motley Fool May 28, 2010 Brian Orelli	This Drug Doesn't Work. But All Is Not Lost. Novartis cancer drug fails one trial, but there's still hope.
AskMen.com Dustin Driver	8 Cancer Myths The following myths about cancer have been debunked by doctors and scientists the world over. So do yourself and your community a favor: read the facts and spread the word.
Chemistry World January 15, 2014 Patrick Walter	Funding confirmed for another 19 doctoral centers David Willetts, the UK's science minister, has announced an additional 40 million pounds for doctoral training in the UK. The extra money came from further industry support and academia, as well as 'renegotiating' some university contracts.
The Motley Fool April 12, 2005 Brian Gorman	Genentech's Cancer Quest The company's achievements in lung cancer further strengthen its reputation as a cancer fighter. Would-be investors are best served by waiting patiently.
The Motley Fool June 15, 2010 Brian Orelli	Just Enough to Give Investors Hope Hitting a secondary endpoint means all is not lost for Onyx's lung cancer drug.
Chemistry World September 2, 2014 Phillip Broadwith	Exelexis slashes workforce by 70% The move follows poor results from a clinical trial of its cancer drug Cometriq (cabozantinib) in men with metastatic castration-resistant prostate cancer.
Chemistry World May 26, 2011 Mike Brown	Ibuprofen: anticancer drug Scientists in the UK have moved a step closer to understanding how ibuprofen could help treat cancer.
Pharmaceutical Executive February 1, 2007 Sarah Houlton	Global Report: Under One Roof The UK government is planning to set up a single body to oversee all health research in universities and hospitals - and to facilitate partnerships between government agencies and industry.
Managed Care March 2007 Lola Butcher	Plans Put Greater Emphasis On Cancer Management Increasingly, health plans are rolling out services designed to help cancer patients and, before that, plan members at a high risk of cancer, to improve their health care and, in doing so, limit costs.
Pharmaceutical Executive February 1, 2013 William Looney	In Cancer, Process Drives Progress Today's most important public health story is the advance in our understanding of the biology of cancer.
The Motley Fool June 23, 2009 Brian Orelli	Wonder Drug! Maybe? Get the facts before jumping on this one.
Chemistry World November 27, 2014 Mark Peplow	It's time to speak up for Europe From the EU funding that British scientists receive, to the benefits of hiring talent from across the continent, the 'science case' for membership is overwhelming.
BusinessWeek February 16, 2004 Catherine Arnst	Medicare vs. Cancer Patients Refusing to reimburse off-label treatment is far from the best way to cut costs.
Chemistry World October 13, 2015 Emma Stoye	Scientists launch campaign to oppose UK exit from EU Several leading scientists have voiced their support for a campaign for the UK to stay in the EU, warning that an exit would harm the country's research base.
Chemistry World September 28, 2012 Andrew Turley	Regorafenib approved in US US authorities have approved Stivarga (regorafenib) tablets for the treatment of advanced colorectal cancer.
Chemistry World March 29, 2007	Sanofi-Aventis and Oxford BioMedica Enter Licensing Agreement UK biotech firm Oxford BioMedica has licensed its leading cancer drug, TroVax, to France's Sanofi-Aventis.
The Motley Fool December 20, 2004 Charly Travers	More Trouble at Big Pharma AstraZeneca's lung cancer drug is not as effective as once hoped.
AskMen.com Jacob Franek	Testicular Cancer Myths While sometimes deciphering the truth is not simple, we dispel five of the most common myths surrounding testicular cancer.
Chemistry World January 13, 2011 Andrew Turley	UK tilts towards appraisal of Avastin as eye drug The UK is moving closer to opening up the National Health Service to cancer drug Avastin (bevacizumab) for the treatment of eye conditions, such as age-related macular degeneration.
The Motley Fool August 22, 2006 Brian Gorman	NICE Unkind to Biotech Developments in the U.K.'s drug coverage may hurt U.S. biotechs. Biotech investors, keep your eyes on this issue.
The Motley Fool February 27, 2004 Alyce Lomax	Genentech's Hope For the past two days, Genentech has been an example of what many investors hinge their hopes and dollars on. Yesterday's FDA approval of the company's groundbreaking cancer drug, Avastin, was the reason positive sentiment remained infectious today.
The Motley Fool June 2, 2011 Luke Timmerman	Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend Infinity Pharmaceuticals' top execs sometimes get strange looks when they say they are developing a new drug for pancreatic cancer. Is this a smart use of the company's time and resources?
The Motley Fool February 13, 2007 Brian Lawler	Rock-Solid News From Onyx Results show that the drug Nexavar works in another type of cancer. But investors need to consider other issues when taking a closer look at this pharma.
CIO May 29, 2014 Stephanie Overby	CIOs Join Forces to Battle Cancer A coalition of healthcare IT chiefs are on a mission to put cancer out of business and share IT best practices, technology tips, and personal support.
Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
Chemistry World July 15, 2008 Hepeng Jia	Testing Times for New Liver Drug AstraZeneca is set to start clinical trials of a liver cancer drug developed for Chinese patients.
Chemistry World April 25, 2014 Emma Stoye	EPSRC announces 83.5m boost for PhD training The Engineering and Physical Sciences Research Council will invest an additional 83.5 million pounds this year in doctoral training partnerships in the UK, universities and science minister David Willetts has announced.
Chemistry World September 10, 2015 Matthew Gunther	Research bodies urge UK government to protect science funding Nearly 200 research organizations have signed an open letter urging the UK government to protect science funding in the 2015 UK spending review.